Bio-Techne Corp - Common Stock (TECH)
75.25
0.00 (0.00%)
Bio-Techne Corp is a biotechnology company that specializes in developing and producing high-quality biotechnology tools and reagents for the life sciences market
The company offers a wide range of products, including proteins, antibodies, assays, and diagnostic tools, which are used by researchers and clinical laboratories for various applications, such as drug development, diagnostics, and disease research. With a focus on innovation, Bio-Techne aims to provide cutting-edge solutions that enhance research capabilities and improve patient outcomes in healthcare.
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · February 5, 2025
![](https://news-assets.stockstory.org/cover-images/illumina-cover-image-71b151373103_2025-01-31-181317_mhxf.jpeg)
Genomics company Illumina (NASDAQILMN) will be reporting results tomorrow after the bell. Here’s what investors should know.
Via StockStory · February 5, 2025
![](https://news-assets.stockstory.org/cover-images/iqvia-cover-image-5d98e4a57389_2025-02-04-170356_lksp.jpeg)
Clinical research company IQVIA (NYSEIQV)
will be announcing earnings results tomorrow before market hours. Here’s what to look for.
Via StockStory · February 5, 2025
![](https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp)
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill · February 5, 2025
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga · August 13, 2024
![](https://news-assets.stockstory.org/cover-images/mettler-toledo-cover-image-6c674ecddb22_2025-01-12-122112_wijq.jpeg)
Precision measurement company Mettler-Toledo (NYSEMTD)
will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via StockStory · February 5, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · February 5, 2025
![](https://news-assets.stockstory.org/cover-images/bio-techne-corporation-cover-image-47c6628d49fc_2025-02-03-172637_gldg.jpeg)
Life sciences company Bio-Techne (NASDAQTECH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 9% year on year to $297 million. Its non-GAAP profit of $0.42 per share was 9.3% above analysts’ consensus estimates.
Via StockStory · February 5, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/15/Wall-Street-bull.png?width=1200&height=800&fit=crop)
Major indices rallied on Wednesday after December inflation data showed underlying price pressures slowing, reducing fears of a prolonged pause in interest rate cuts by the Federal Reserve.
Via Benzinga · January 15, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/05/7-Software-Stocks-Ready-To-Profit-From-C_0.jpeg?width=1200&height=800&fit=crop)
Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.
Via Benzinga · February 5, 2025
![](https://cdn.benzinga.com/files/images/story/2024/11/13/inflation-shutter3.jpeg?width=1200&height=800&fit=crop)
October inflation data meets expectations with a slight uptick in annual rate, core inflation steady at 3.3%. Fed may cut rates in Dec. Market reacts positively.
Via Benzinga · November 13, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/11/Monster-Energy-logo.jpeg?width=1200&height=800&fit=crop)
These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. being the worst performers.
Via Benzinga · August 11, 2024
![](https://investorplace.com/wp-content/uploads/2019/07/tech1600.jpg)
TECH stock results show that Bio-Techne met analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Via InvestorPlace · August 7, 2024
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600gene.jpg)
These are three of the best genomics stocks to buy for a lucrative entry into a specialized section of the biotech industry.
Via InvestorPlace · August 6, 2024
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
Via InvestorPlace · July 9, 2024
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
Thanks to the underlying pertinence, these established biotech stocks to buy offer confidence to investors facing tricky market conditions.
Via InvestorPlace · May 20, 2024
![](https://cdn.pixabay.com/photo/2020/06/11/19/51/mockup-5288033_960_720.jpg)
Wall Street has regained momentum in recent sessions, with the S&P 500 Index logging the fourth consecutive gain. The benchmark reclaimed the 5,200 level in the latest trading session before ending below the level.
Via Talk Markets · May 9, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/05/Top-Performer.jpeg?width=1200&height=800&fit=crop)
Last week's top performers included Carvana, Pinterest, Moderna and JD.Com.
Via Benzinga · May 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/01/amd-shutter.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 1, 2024
![](https://investorplace.com/wp-content/uploads/2019/07/tech1600.jpg)
TECH stock results show that Bio-Techne beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via InvestorPlace · May 1, 2024